[19] [20] If heartburn significantly impacts your quality of life or adherence to semaglutide therapy, your provider can discuss alternative GLP-1 receptor agonists, dose adjustments, or complementary treatments to optimize both diabetes or weight management and gastrointestinal comfort
Stabilized blood sugar levels: Improved blood sugar control is a crucial indicator of semaglutide's effectiveness, especially for individuals with type 2 diabetes
These same molecules were also subsequently approved for weight lossliraglutide in 2014, and semaglutide, as Wegovy, in 2021
That's it.
This sparked research that eventually led to their approval as an obesity treatment in people with or without diabetes
It reads pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that describe your baseline GLP-1 and energy-balance biology context to inform a provider conversation, not a prediction of results